BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Iovance Biotherapeutics Inc. (NASDAQ:IOVA)

3 posts

Biotech News44% Real-World Response? Iovance (IOVA) Just Made “Off-the-Bench” Data the New Headline

  • BioTech Health X
  • February 13, 2026
We recently published our article Top 10 Cancer Biotech Small-Caps That Could Shock the Market Next. This piece…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Cancer Biotech Small-Caps That Could Shock the Market Next

  • BioTech Health X
  • February 13, 2026
In this article, we will take a look at the Top 10 Cancer Biotech Small-Caps That Could Shock…
0 Shares
0
0
0
0
0
0
0

Biotech NewsIovance Bio (IOVA): The Most Undervalued Cancer Stock in the Market

  • BioTech Health X
  • November 8, 2025
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is a pioneering biotechnology company dedicated to transforming cancer treatment through cell-based immunotherapies…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Here’s What Makes Adaptimmune Therapeutics (ADAPY) a Smart Long-Term Investment
  • Is it Still Safe to Buy Eton Pharmaceuticals (ETON) Shares?
  • Is it Still a Wise Move to Invest in Rocket Pharmaceuticals (RCKT)?
  • Is it Time to Take Profit in Cingulate (CING)?
  • Should You Now Consider Buying Vir Biotechnology (VIR) Shares?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • March 1, 2026
    Here’s What Makes Adaptimmune Therapeutics (ADAPY) a Smart Long-Term Investment
    • March 1, 2026
    Is it Still Safe to Buy Eton Pharmaceuticals (ETON) Shares?
    • March 1, 2026
    Is it Still a Wise Move to Invest in Rocket Pharmaceuticals (RCKT)?
    • March 1, 2026
    Is it Time to Take Profit in Cingulate (CING)?
    • March 1, 2026
    Should You Now Consider Buying Vir Biotechnology (VIR) Shares?
Recent Posts
  • Is Arvinas Inc. (ARVN) a Smart Long-Term Investment?
    • March 1, 2026
  • Here’s What Makes Corvus Pharmaceuticals (CRVS) a Wise Investment Pick
    • March 1, 2026
  • Here’s Why You Should Invest in Travere Therapeutics (TVTX)
    • March 1, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (798)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top